Insider buying
~$1M32K sh @ $31.76
Traded Mar 3, 2025 · filed 1 day later
A Moderna director paid $1M out of pocket for Moderna shares. 1 other person at Moderna bought some too, in the same month. Shares held went up 11% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Sep 30, 2024 (Q3 2024) · Filed Feb 14, 2025
35 tracked managers disclosed the same change for Q3 2024. From a 13F filed Feb 14, 2025 covering holdings at Sep 30, 2024 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Increased
Compared with the manager's Q2 2024 13F
1,300,000
3,500,000
+169.2%
Share count drives classification; reported value also moves with price
1.12%
Within the filing's reported positions, not the manager's total assets
35
For Q3 2024
PUT options
Options are tracked separately from common stock
Insider buying
Traded Mar 3, 2025 · filed 1 day later
A Moderna director paid $1M out of pocket for Moderna shares. 1 other person at Moderna bought some too, in the same month. Shares held went up 11% with this purchase.
Insider buying
Traded Mar 3, 2025 · filed 1 day later
The CEO of Moderna paid $3.19M out of pocket for Moderna shares. 1 other person at Moderna bought some too, in the same month.
Insider buying
Traded Mar 3, 2025 · filed 1 day later
The CEO of Moderna paid $1.81M out of pocket for Moderna shares. 1 other person at Moderna bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.